Caren Wilkie, MD
Surgery · Daytona Beach, FLNPI 1588651699
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,493 of the $3,901 with a category attached, or 89.5%. It is spread thinly across 25 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.
Across 157 payments — averaging $24.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$504
- Novartis$457
- Elucent Medical$408
- Lilly USA, LLC$374
- Seagen Inc.$277
- Merck$258
- plus $2K from 19 others
What the payments were for
- Travel & lodging$40810%
- Food & beverage$3,49390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 21 | $504 |
| Novartis | 23 | $457 |
| Elucent Medical | 1 | $408 |
| Lilly USA, LLC | 20 | $374 |
| Seagen Inc. | 16 | $277 |
| Merck | 9 | $258 |
| Amgen | 13 | $247 |
| AstraZeneca | 8 | $237 |
| Novo Nordisk | 2 | $144 |
| Foundation Medicine, Inc. | 4 | $130 |
| Dilon Technologies, Inc. | 3 | $118 |
| Johnson & Johnson | 2 | $115 |
| Incyte Corporation | 8 | $113 |
| Genentech USA, Inc. | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Puma Biotechnology, Inc. | 5 | $73 |
| Eisai Inc. | 3 | $71 |
| ADC Therapeutics America, Inc. | 2 | $54 |
| Pfizer | 2 | $39 |
| Heron Therapeutics, Inc. | 1 | $27 |
| Sanofi | 1 | $22 |
| KCI USA, Inc. | 1 | $16 |
| Myriad Genetic Laboratories, Inc. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| Focal Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$101
How this compares
$3,901 in reported general payments places this provider in the 55th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 15 | $270 |
Paid to pharmacies, not to this prescriber.
Other surgery in Daytona Beach
- Bruce RamshawDaytona Beach$78K
- Jorge FlorinWinter Garden$2.2M
- Amit TaggarTampa$1.4M
- Keith KimCelebration$1.1M
- Richard DiciccoTampa$964K
- Elizabeth DovecLakeland$870K
- Christopher DucoinTampa$808K
- Andre TeixeiraOcala$731K
- Jose ErbellaBradenton$718K
- Anthony GonzalezMiami$686K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.